Answers are grounded in this paper and cite their sources.
; 93% received zidovudine-containing ART; infants received nevirapine up to 6 weeks and cotrimoxazole after 6 weeks. Among 84 infants at 19 weeks, 58% had hematologic toxicity; 44% had neutropenia and 23% had anemia. Breastfeeding was associated with 3.8-fold higher risk of neutropenia (RR 3.8, 95% CI 1.03-14.1, p = 0.008). Hematologic monitoring and PMTCT regimen selection are important for optimizing infant outcomes.
No takes yet. Share an insight, caveat, or question.
Njuguna et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: